UnitedHealth Group (NYSE: UNH) reported earnings on July 18. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended June 30 (Q2), UnitedHealth Group met expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded. GAAP earnings per share grew.

Gross margins grew, operating margins shrank, net margins dropped.

Revenue details
UnitedHealth Group reported revenue of $30.41 billion. The 13 analysts polled by S&P Capital IQ expected sales of $30.51 billion on the same basis. GAAP reported sales were 12% higher than the prior-year quarter's $27.27 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $1.40. The 21 earnings estimates compiled by S&P Capital IQ averaged $1.25 per share. GAAP EPS of $1.40 for Q2 were 10% higher than the prior-year quarter's $1.27 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 27.1%, 50 basis points better than the prior-year quarter. Operating margin was 7.9%, 30 basis points worse than the prior-year quarter. Net margin was 4.7%, 20 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)

Looking ahead
Next quarter's average estimate for revenue is $30.74 billion. On the bottom line, the average EPS estimate is $1.54.

Next year's average estimate for revenue is $122.86 billion. The average EPS estimate is $5.45.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 3,307 members out of 3,460 rating the stock outperform, and 153 members rating it underperform. Among 1,057 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 1,041 give UnitedHealth Group a green thumbs-up, and 16 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on UnitedHealth Group is buy, with an average price target of $70.52.

Is UnitedHealth Group the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.